1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 5,460 | 5,640 | 16:51 |
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 13.10. | SMAIO Reports First-Half 2026 Results and Sales for the Third Quarter of 2026 | 509 | Business Wire | Half-year sales rose by 3% to €5.1m, driven by implant sales in the United States, which increased by 3% to €3.9m (up 10% to $4.5m, excluding currency effects)
Solid gross margin of 81%... ► Artikel lesen | |
| 06.10. | SMAIO Signs a New Collaboration for its KEOPS-4ME Open Platform in the United States | 458 | Business Wire | This new agreement marks the acceleration of SMAIO's collaborative strategy aimed at rolling out its open platform for customized implant solutions in the US market.
Regulatory News:
SMAIO... ► Artikel lesen | |
| 03.09. | SMAIO has Reappointed Dr Donald J. Blaskiewicz to its Scientific Advisory Board in the United States | 480 | Business Wire | Regulatory news:
SMAIO (Software, Machines and Adaptative Implants in Orthopaedics Euronext Growth Paris, ISIN code: FR0014005I80 Ticker: ALSMA, PEA-PME eligible), a French-American company specialized... ► Artikel lesen | |
| 16.07. | SMAIO Reports Sales for the First Half of 2026 | 484 | Business Wire | Up 3% to €5.1m, first-half sales exceeded the €5m mark for the first time, despite four months of temporary absence of one of the top-performing surgeons in the United States
U.S. sales... ► Artikel lesen | |
| 12.05. | SMAIO Reported Revenue of €2.8 Million in the First Quarter of 2026, an Increase of 11% | 500 | Business Wire | Revenue in the United States reached a record quarterly high of €2.3 million (+21%), or $2.6 million (+35%)1 excluding currency effects
The United States accounts for nearly 80% of the... ► Artikel lesen | |
| 11.05. | SMAIO Expands Its North American Scientific Advisory Board With a New Renowned Surgeon | 441 | Business Wire | Appointment of Dr. Jeffrey M. Hills, an orthopedic surgeon specializing in complex spinal conditions SMAIO's Scientific Advisory Board, now comprised of five members, is a key asset in... ► Artikel lesen | |
| 05.05. | SMAIO Announces that Portzamparc (BNP Paribas Group) has Initiated Coverage of its Stock with a Buy Rating | 576 | Business Wire | Regulatory News:
SMAIO (Software, Machines and Adaptive Implants in Orthopaedics Euronext Growth Paris, ISIN Code: FR0014005I80 Ticker: ALSMA), a French-American company specialized in complex... ► Artikel lesen | |
| 06.03. | SMAIO Announces a €3.6 Million Capital Increase to Support Its Long-Term Growth Momentum | 711 | Business Wire | Capital increase totaling €3.6 million gross through the issuance of shares with stock warrants (ABSAs) at a price of €7 per share
4 warrants will entitle the holder to subscribe for one... ► Artikel lesen | |
| S.M.A.I.O SA Aktie jetzt für 0€ handeln | |||||
| 20.01. | SMAIO Reports 2025 Sales of €9.2m, Representing an Increase of +67% | 536 | Business Wire | U.S. sales rose by +138% to €7m, and by +160% to $7.9m (excluding currency effects).
Strong growth across North American centers that were already active in 2024 (+130%). 11 new... ► Artikel lesen | |
| 08.01. | SMAIO: 2026 Financial Calendar | 642 | Business Wire | Regulatory News:
SMAIO (Software, Machines and Adaptive Implants in Orthopaedics Euronext Growth Paris, ISIN: FR0014005I80 Ticker: ALSMA), a French-American player specialized in complex spine... ► Artikel lesen | |
| 06.01. | SMAIO Obtains €2.0m in Non-Dilutive Financing | 596 | Business Wire | €1.0m in the form of a 0% interest loan co-financed by the European Union, the Auvergne-Rhône-Alpes Region and Bpifrance, with a repayment deferral period of two and a half years €1.0m... ► Artikel lesen | |
| 19.12.25 | SMAIO Successfully Continues Its Think Tanks Focused on Promoting Its Innovative Solutions in the United States | 882 | Business Wire | New attendance record at the New York session, bringing together nearly 60 experts from the spine sector, including over 40 surgeons
Regulatory News:
SMAIO (Software, Machines and Adaptative... ► Artikel lesen | |
| 24.11.25 | SMAIO Appoints Matthieu Ville as Chief Commercial Officer to Accelerate Commercialization and Strengthen Its Leadership in Spinal Realignment | 474 | Business Wire | Matthieu Ville brings over 15 years of experience in medical marketing in the United States.
Regulatory News:
SMAIO (Software, Machines and Adaptative Implants in Orthopaedics- Euronext Growth... ► Artikel lesen | |
| 03.11.25 | SMAIO Adds a New High-Profile Member to Its Scientific Advisory Board in the United States | 511 | Business Wire | Appointment of Dr. Tenner Guillaume, Orthopaedic spine surgeon who specializes in spinal deformity at Gillette Children's Hospital (St. Paul, Minnesota). SMAIO's US scientific advisory board... ► Artikel lesen |
14 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FRESENIUS MEDICAL CARE | 40,440 | -2,48 % | JPMORGAN stuft FMC FRESENIUS MEDICAL CARE AG auf 'Underweight' | NEW YORK (dpa-AFX Analyser) - Die US-Bank JPMorgan hat FMC auf "Underweight" mit einem Kursziel von 32,30 Euro belassen. Entgegen seinen Erwartungen seien die Konsensschätzungen an die Quartalszahlen... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 66,18 | +9,89 % | BrightSpring Health Q3 2026 Earnings Call Transcript | ||
| SIEMENS HEALTHINEERS | 42,830 | -0,14 % | EQS-CMS: Siemens Healthineers AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Siemens Healthineers AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b), Abs. 3 der Verordnung (EU) Nr. 596/2014, zuletzt geändert durch die Verordnung... ► Artikel lesen | |
| FRESENIUS | 47,705 | +1,50 % | BERENBERG stuft Fresenius SE auf 'Buy' | HAMBURG (dpa-AFX Analyser) - Die Privatbank Berenberg hat das Kursziel für Fresenius von 50 auf 54 Euro angehoben und die Einstufung auf "Buy" belassen. Der Markt bewerte den Medizinkonzern als vom... ► Artikel lesen | |
| GERRESHEIMER | 32,280 | +1,19 % | Kurssprünge und neue Aufträge: Wie belastbar ist die Wende? dynaCERT, Gerresheimer, Steyr Motors | Ein Übernahmeangebot, internationale Vertriebsfortschritte und ein Konzernumbau bringen Bewegung in die folgenden drei Börsenwerte. Während Anleger auf neue Wachstumsimpulse und finanzielle Entlastung... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 7,460 | -7,44 % | Piper Sandler cuts Alignment Healthcare stock price target on weak guidance | ||
| HEARTFLOW | 57,83 | -4,47 % | Biotech Stocks At 52-Week Highs - Vaxcyte +31% On Phase 3 Results, InfuSystem, Illumina +7%, Charles River Laboratories +7%, HeartFlow +5% | SAN DIEGO (dpa-AFX) - The following biotech stocks reached a 52-week high on October 5, 2026, driven by key catalysts such as encouraging clinical research data.Vaxcyte Inc. (PCVX)Vaxcyte is... ► Artikel lesen | |
| GENEDX | 70,41 | -0,86 % | GeneDx plans to add long-read genome sequencing to portfolio | ||
| CARL ZEISS MEDITEC | 35,620 | +2,47 % | JPMORGAN stuft CARL ZEISS MEDITEC AG auf 'Underweight' | NEW YORK (dpa-AFX Analyser) - Die US-Bank JPMorgan hat Carl Zeiss Meditec auf "Underweight" mit einem Kursziel von 18,10 Euro belassen. Für die Quartalszahlen am 10. Dezember liege er beim Umsatz auf... ► Artikel lesen | |
| BASEL MEDICAL GROUP | 4,950 | +4,21 % | Basel Medical Group Ltd - 20-F, Annual and transition report of foreign private issuers | ||
| LIFESTANCE HEALTH GROUP | 13,525 | 0,00 % | LifeStance Health Group, Inc.: LifeStance Reports Strong Second Quarter 2026 Financial Results and Raises Full Year Outlook | SCOTTSDALE, Ariz., Aug. 06, 2026 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (Nasdaq: LFST), one of the nation's largest providers of outpatient mental healthcare, today announced financial... ► Artikel lesen | |
| UNITEDHEALTH | 364,80 | -1,08 % | UnitedHealth Group To Rally Over 29%? Here Are 10 Top Analyst Forecasts For Tuesday | ||
| BILLIONTOONE | 111,74 | -2,70 % | BillionToOne, Inc.: BillionToOne's Tissue-Free Northstar Response Demonstrates On-Par to Superior Cancer Treatment Monitoring vs. Tumor-Informed Assay, New Peer-Reviewed Study Finds | MENLO PARK, Calif., Oct. 07, 2026 (GLOBE NEWSWIRE) -- BillionToOne, Inc. (Nasdaq: BLLN), a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that are... ► Artikel lesen | |
| BETA BIONICS | 17,140 | -2,50 % | Truist reiterates Buy on Beta Bionics stock, $28 target on MINT | ||
| ECKERT & ZIEGLER | 13,435 | +1,63 % | EQS-News: Eckert & Ziegler SE: Eckert & Ziegler Erhält GMP-Zertifizierung für Actinium-225 | EQS-News: Eckert & Ziegler SE
/ Schlagwort(e): Zulassungsgenehmigung
Eckert & Ziegler Erhält GMP-Zertifizierung für Actinium-225
28.10.2026 / 14:00 CET/CEST
Für den... ► Artikel lesen |
Das Unternehmen S.M.A.I.O SA kann der Branche Gesundheitswesen zugeordnet werden. Die relative Kursveränderung beträgt aktuell 0,00 % bei einem Aktienkurs von 5,500 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu S.M.A.I.O SA finden Sie auf Wallstreet Online.